Delivery Order SPE2DB22D3301-SPE2DB25FX8ZC
Award Date
1/24/25
Potential Completion Date
2/14/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,971.64, is for the delivery of ZOLADEX 3.6 MG IMPLANT SYRNS, a pharmaceutical product. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,619.40, is for the supply of ZOLADEX 3.6 MG IMPLANT SYRNS, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 15, 2025. This award is not designated as a set-aside contract. The contract is associated with a...
This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of ZOLADEX 3.6 MG IMPLANT SYRNS. The contract has a firm fixed price of $2,647.76 and an ultimate completion date of April 24, 2025. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,985.82, is for the supply of ZOLADEX 3.6 MG IMPLANT SYRNS, a specialized medical product. The contract has a firm fixed price pricing structure and a completion date of February 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,985.82 firm fixed-price contract is for the supply of ZOLADEX 3.6 MG IMPLANT SYRNS, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,263.74 firm fixed-price delivery order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a medical product related to healthcare. The contract has an ultimate completion date of November 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,323.88 firm fixed-price delivery order is for ZOLADEX 3.6 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has an ultimate completion date of April 22, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,677.52, is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty medication. The award was made on December 23, 2022, with a completion date of January 18, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $2,647.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZOLADEX 3.6 MG IMPLANT SYRNS, a medical product, with a performance period ending on March 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of 4,565,080,587 units of the pharmaceutical product ZOLADEX 3.6 MG IMPLANT SYRNS. The single-award Indefinite Delivery Contract (IDC) is valued at up to $1,249.20 and was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The contract does not have a set-aside designation and runs through July 26, 2024. Amerisourcebergen, a major...